Patents Assigned to Viacyte, Inc.
  • Patent number: 9132226
    Abstract: The present invention relates to methods for encapsulating pancreatic progenitors in a biocompatible semi-permeable encapsulating device. The present invention also relates to production of human insulin in a mammal in response to glucose stimulation.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: September 15, 2015
    Assignee: ViaCyte, Inc.
    Inventors: Laura Martinson, Chad Green, Evert Kroon, Emmanuel Edward Baetge
  • Patent number: 9109245
    Abstract: Disclosed herein are cell culture compositions, for example, pancreatic cell culture compositions, derived from dedifferentiated human reprogrammed pluripotent stem cells, such as induced pluripotent stem (iPS) cells, and methods for producing and using such cell culture compositions.
    Type: Grant
    Filed: February 6, 2013
    Date of Patent: August 18, 2015
    Assignee: ViaCyte, Inc.
    Inventors: Alan D. Agulnick, Olivia Kelly, Yuki Ohi, Allan Robins, Thomas Schultz
  • Patent number: 9045736
    Abstract: The present disclosure relates to compositions and methods comprising cell surface markers for hES-derived cells, in particular, endoderm lineage cells including pancreatic endoderm-type cells, derived from hES cells.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: June 2, 2015
    Assignee: ViaCyte, Inc.
    Inventors: Olivia Kelly, Anne Bang
  • Patent number: 8895300
    Abstract: The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: November 25, 2014
    Assignee: Viacyte, Inc.
    Inventor: Thomas C Schulz
  • Patent number: 8859286
    Abstract: A human immature endocrine cell population and methods for making an immature endocrine cell population are provided. Specifically, immature beta cells and methods for production of immature beta cells are described. Immature beta cells co-express INS and NKX6.1 and are uni-potent and thereby develop into mature beta cells when implanted in vivo. The mature beta cells in vivo are capable of producing insulin in response to glucose stimulation.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: October 14, 2014
    Assignee: ViaCyte, Inc.
    Inventor: Alan D. Agulnick
  • Publication number: 20140271566
    Abstract: A human immature endocrine cell population and methods for making an immature endocrine cell population are provided. Specifically, immature beta cells and methods for production of immature beta cells are described. Immature beta cells co-express INS and NKX6.1 and are uni-potent and thereby develop into mature beta cells when implanted in vivo. The mature beta cells in vivo are capable of producing insulin in response to glucose stimulation.
    Type: Application
    Filed: December 13, 2013
    Publication date: September 18, 2014
    Applicant: ViaCyte, Inc.
    Inventor: Alan D. Agulnick
  • Patent number: D714956
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: October 7, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Vincent So, Laura Martinson, Chad Green, Michael Scott
  • Patent number: D718466
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: November 25, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Vincent So, Laura Martinson, Chad Green, Michael Scott
  • Patent number: D718467
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: November 25, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Vincent So, Laura Martinson, Chad Green, Michael Scott
  • Patent number: D718468
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: November 25, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Vincent So, Laura Martinson, Chad Green, Michael Scott
  • Patent number: D718469
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: November 25, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Vincent So, Laura Martinson, Chad Green, Michael Scott
  • Patent number: D718470
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: November 25, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Vincent So, Laura Martinson, Chad Green, Michael Scott
  • Patent number: D718471
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: November 25, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Vincent So, Laura Martinson, Chad Green, Michael Scott
  • Patent number: D718472
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: November 25, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Vincent So, Laura Martinson, Chad Green, Michael Scott
  • Patent number: D720469
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: December 30, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Chad Green, Vincent So, Laura Martinson, Michael Scott
  • Patent number: D726306
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: April 7, 2015
    Assignee: Viacyte, Inc.
    Inventor: Chad Green
  • Patent number: D726307
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: April 7, 2015
    Assignee: Viacyte Inc.
    Inventor: Chad Green
  • Patent number: D728095
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: April 28, 2015
    Assignee: Viacyte, Inc.
    Inventor: Chad Green
  • Patent number: D734166
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: July 14, 2015
    Assignee: VIACYTE, INC.
    Inventors: Erik Olson, Michael Scott, Donald Koenig
  • Patent number: D734847
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: July 21, 2015
    Assignee: VIACYTE, INC.
    Inventor: Chad Green